These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11597351)
41. Entrapment of small molecules and nucleic acid-based drugs in liposomes. Fenske DB; Cullis PR Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372 [TBL] [Abstract][Full Text] [Related]
42. Somatic gene targeting with RNA/DNA chimeric oligonucleotides: an analysis with a sensitive reporter mouse system. Ino A; Yamamoto S; Kaneda Y; Kobayashi I J Gene Med; 2004 Nov; 6(11):1272-80. PubMed ID: 15459966 [TBL] [Abstract][Full Text] [Related]
43. Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria. Bai J; Yang E; Chang PS; Ryu S Enzyme Microb Technol; 2019 Sep; 128():40-48. PubMed ID: 31186109 [TBL] [Abstract][Full Text] [Related]
44. Application of ultrasonic gas-filled liposomes in enhancing transfer for breast cancer-related antisense oligonucleotides: an experimental study. Luo YK; Zhao YZ; Lu CT; Tang J; Li XK J Liposome Res; 2008; 18(4):341-51. PubMed ID: 18985510 [TBL] [Abstract][Full Text] [Related]
45. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides]. Chen HL; Liang WQ; Shao JB; Chen Z Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587 [TBL] [Abstract][Full Text] [Related]
46. Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy. Wang Z; Ma Y; Khalil H; Wang R; Lu T; Zhao W; Zhang Y; Chen J; Chen T Int J Nanomedicine; 2016; 11():4025-36. PubMed ID: 27574430 [TBL] [Abstract][Full Text] [Related]
48. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Mathew E; Hardee GE; Bennett CF; Lee KD Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441 [TBL] [Abstract][Full Text] [Related]
49. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Good L; Nielsen PE Nat Biotechnol; 1998 Apr; 16(4):355-8. PubMed ID: 9555726 [TBL] [Abstract][Full Text] [Related]
50. Antisense imaging of colon cancer-bearing nude mice with liposome-entrapped 99m-technetium-labeled antisense oligonucleotides of c-myc mRNA. Zheng JG; Tan TZ World J Gastroenterol; 2004 Sep; 10(17):2563-6. PubMed ID: 15300907 [TBL] [Abstract][Full Text] [Related]
51. [Optimal effects of liposome on antisense oligodeoxynucleotides uptake by mouse breast cancer TM40D cells and the effects of antisense oligodeoxynucleotides targeting c-erbB-2 on cell proliferation and apoptosis]. Liu XA; Fan P; Wu ZY Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):802-5. PubMed ID: 15363300 [TBL] [Abstract][Full Text] [Related]
52. Artificial antisense RNAs silence lacZ in E. coli by decreasing target mRNA concentration. Alessandra S; Alessandro T; Flavio S; Alejandro H BMB Rep; 2008 Aug; 41(8):568-74. PubMed ID: 18755071 [TBL] [Abstract][Full Text] [Related]
53. Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide). Skalickova S; Nejdl L; Kudr J; Ruttkay-Nedecky B; Jimenez AM; Kopel P; Kremplova M; Masarik M; Stiborova M; Eckschlager T; Adam V; Kizek R Sensors (Basel); 2016 Feb; 16(3):290. PubMed ID: 26927112 [TBL] [Abstract][Full Text] [Related]
54. Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation. Shao Y; Wu Y; Chan CY; McDonough K; Ding Y Nucleic Acids Res; 2006; 34(19):5660-9. PubMed ID: 17038332 [TBL] [Abstract][Full Text] [Related]
55. EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line. Najar AG; Pashaei-Asl R; Omidi Y; Farajnia S; Nourazarian AR Asian Pac J Cancer Prev; 2013; 14(1):495-8. PubMed ID: 23534780 [TBL] [Abstract][Full Text] [Related]
56. Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities. Brignole C; Marimpietri D; Pagnan G; Di Paolo D; Zancolli M; Pistoia V; Ponzoni M; Pastorino F Cancer Lett; 2005 Oct; 228(1-2):181-6. PubMed ID: 15936140 [TBL] [Abstract][Full Text] [Related]
57. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis. Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520 [TBL] [Abstract][Full Text] [Related]
58. Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer. Morishita R; Gibbons GH; Horiuchi M; Nakajima M; Ellison KE; Lee W; Kaneda Y; Ogihara T; Dzau VJ J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):213-222. PubMed ID: 10684460 [TBL] [Abstract][Full Text] [Related]
59. Cationic liposome--plasmid DNA complexes used for gene transfer retain a significant trapped volume. Wasan EK; Fairchild A; Bally MB J Pharm Sci; 1998 Jan; 87(1):9-14. PubMed ID: 9452961 [TBL] [Abstract][Full Text] [Related]
60. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. Bandyopadhyay P; Ma X; Linehan-Stieers C; Kren BT; Steer CJ J Biol Chem; 1999 Apr; 274(15):10163-72. PubMed ID: 10187800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]